Type 2 Diabetes
Showing NaN - NaN of 51
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching with Dapagliflozin, Saxagliptin)
Type 2 Diabetes, Obesity, Diabesity Trial in Birmingham, Glasgow, London (Liraglutide, Duodenal-jejunal bypass liner -
Unknown status
- Type 2 Diabetes
- +2 more
- Liraglutide
- Duodenal-jejunal bypass liner - Endobarrier device
-
Birmingham, United Kingdom
- +3 more
Apr 25, 2016
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Type 2 Diabetes Trial in United States (ITCA 650, ITCA )
Completed
- Type 2 Diabetes
- ITCA 650
- ITCA placebo
-
Birmingham, Alabama
- +121 more
Jul 28, 2015
Type 2 Diabetes Trial in Worldwide (Saxagliptin, 5 mg + insulin, Placebo + insulin)
Completed
- Type 2 Diabetes
- Saxagliptin, 5 mg + insulin
- Placebo + insulin
-
Tempe, Arizona
- +79 more
May 8, 2015
Type 2 Diabetes, Hypogonadism Trial in United States (Androgel (testosterone gel))
Completed
- Type 2 Diabetes
- Hypogonadism
- Androgel (testosterone gel)
-
Birmingham, Alabama
- +69 more
Jan 19, 2015
A 2-Month Safety Follow-Up Trial
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Technosphere Insulin Inhalation Powder
- Comparator
-
Birmingham, Alabama
- +149 more
Dec 1, 2014
Type 2 Diabetes, Overweight, Obesity Trial in United States (Weight Watchers modified program, Standard Care group)
Completed
- Type 2 Diabetes
- +2 more
- Weight Watchers modified program
- Standard Care group
-
Birmingham, Alabama
- +14 more
Oct 14, 2014
Chronic Periodontitis, Type 2 Diabetes Trial in United States (Non-surgical periodontal therapy, Delayed non-surgical
Completed
- Chronic Periodontitis
- Type 2 Diabetes
- Non-surgical periodontal therapy
- Delayed non-surgical periodontal therapy
-
Birmingham, Alabama
- +7 more
Jan 17, 2014
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo)
Chronic Kidney Disease, Type 2 Diabetes, Diabetic Nephropathy Trial in United States (Placebo, Bardoxolone Methyl (RTA 402))
Completed
- Chronic Kidney Disease
- +2 more
- Placebo
- Bardoxolone Methyl (RTA 402)
-
Birmingham, Alabama
- +41 more
Jun 12, 2012
Type 2 Diabetes Trial in Worldwide (Lapaquistat acetate and lipid-lowering therapy, Lipid-lowering therapy)
Completed
- Type 2 Diabetes
- Lapaquistat acetate and lipid-lowering therapy
- Lipid-lowering therapy
-
Tucson, Arizona
- +76 more
May 23, 2012
Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)
Completed
- Type 2 Diabetes
- Colesevelam hydrochloride
-
Birmingham, Alabama
- +46 more
Jan 16, 2012
Type 2 Diabetes Trial in Birmingham (Glucose potassium insulin solution)
Unknown status
- Type 2 Diabetes
- Glucose potassium insulin solution
-
Birmingham, West Midlands, United KingdomUniversity Hospital Birmingham
May 11, 2009
G-PLUS
Terminated
- Type 2 Diabetes
-
Birmingham, Alabama
- +542 more
Mar 14, 2008
Type 2 Diabetes Trial in Worldwide (Tesaglitazar 0.5 or 1 mg, Glibenclamide 2.5, 5, 10 or 15 mg)
Terminated
- Type 2 Diabetes
- Tesaglitazar 0.5 or 1 mg
- Glibenclamide 2.5, 5, 10 or 15 mg
-
Adelaide, Australia
- +83 more
Mar 14, 2008
Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)
Completed
- Type 2 Diabetes
- Colesevelam hydrochloride
-
Birmingham, Alabama
- +63 more
Dec 26, 2007